BofA’s Top 4 Biotechs for 2026
With 2025 winding down, many investors are still looking for new ideas for their 2026 investing ...
Read moreDetailsWith 2025 winding down, many investors are still looking for new ideas for their 2026 investing ...
Read moreDetailsRight now the market is driven by uncertainty. Tariffs into a trade war, political infighting, attacking ...
Read moreDetailsInvestors have been having a hard time in 2025. The initial "Trump Bump" has so far ...
Read moreDetailsDonald Trump has now officially been sworn in as the 47th President of the United States. ...
Read moreDetailsStocks were bouncing on Friday morning after the first trading day of 2025 failed to show ...
Read moreDetailsStocks were looking weak again on Friday on continued selling pressure ahead of key inflation data. ...
Read moreDetailsStocks were mixed with no real direction on Monday despite more telegraphed stimulus coming out of ...
Read moreDetails
Oggonomics delivers daily stock analysis, Wall Street analyst coverage, and no-nonsense market commentary for investors who think for themselves.
Learn more

Subscribe to our weekly newsletter below and keep up with Oggonomics articles.